SCHEMBL23615939

SCHEMBL23615939

C=C(c1ccc(N2CCC2)cc1)C(C)c1ccc(CC)c(CCC)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 5/20 0.42
▸ ALDH1A1 P00352 5/20 0.34
▸ MAPT P10636 2/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ SMYD3 Q9H7B4 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ EPHX2 P34913 1/20 0.33
▸ NR1H4 Q96RI1 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ GRIN2D O15399 1/20 0.33
▸ GRIN3B O60391 1/20 0.33
▸ F2 P00734 1/20 0.33
▸ PRSS1 P07477 1/20 0.33
▸ PRSS2 P07478 1/20 0.33
▸ PRSS3 P35030 1/20 0.33
▸ GRIN1 Q05586 1/20 0.33
▸ GRIN2A Q12879 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23615998 0.91 HIF1A (0.48) HIF1AALDH1A1MAPTNPSR1SMYD3
SCHEMBL23615933 0.76 CYP2D6 (0.44) HIF1AALDH1A1MAPTKDM4ENPC1
SCHEMBL19675453 0.70 MAPT (0.50) HIF1AALDH1A1MAPTNPSR1KDM4E
SCHEMBL24751622 0.66 PPARG (0.40) HIF1AALDH1A1LMNA
SCHEMBL27249154 0.61 CHKA (0.51) ALDH1A1MAPTKDM4ENPC1TP53
SCHEMBL18118174 0.61 HPGD (0.52) ALDH1A1MAPTNPSR1KDM4ENPC1
SCHEMBL15893978 0.61 HIF1A (0.58) HIF1AALDH1A1MAPTNPSR1KDM4E
SCHEMBL16564077 0.61 HTT (0.57) ALDH1A1MAPTNPSR1KDM4ENPC1
SCHEMBL28745217 0.61 MAPT (0.54) HIF1AALDH1A1MAPTNPSR1KDM4E
SCHEMBL10473871 0.61 KMT2A (0.47) ALDH1A1MAPTNPSR1KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3845516-A1 NOVEL HIF-1alfa INHIBITOR, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ANGIOGENESIS-ASSOCIATED EYE DISEASE, CONTAINING SAME AS ACTIVE INGREDIENT Seoul National University R & DB Foundation (KR) 2021-07-07 — — EP disclosed
Send feedback